Amarin Corp Plc (AMRN)

[couldbebetter]

Zip, If I could ask Alex Denner any question it would be is he aware of the
potential of Vascepa (or an EPA derivative) as an adjunct drug for any cancer
drug/therapy? If he his, could that be a selling point in getting a BP to acquire
AMRN? (I really would like to know if people such as him or Dr. Bhatt believe
that area would be worth pursuing.) It bothers me that is an area that is not
even discussed except for the occasional comment by you or me. The
potential if EPA were proven effective would be potentially massive...Yet,
there really appears to be no interest (by AMRN management at least) in
finding this out. I have mentioned years ago that a trial could be run with
Keytruda that would be relatively simple to do. Why wouldn't someone
like Dr. Bhatt pursue this?